A home use medical device or home medical device is intended for patients (care recipient) in any environment. This includes devices intended for use in both professional healthcare facilities and homes. Additionally, changes in healthcare have encouraged care from the hospital environment to the home environment. Home medical device may include glucose meter, heating pad, hospital bed, walker, ventilator, wheelchair and others.
F. Hoffmann-La Roche Ltd., and General Electric Company – Notable Market Players in Home Medical Devices Market
Market leaders operating in the market have undertaken various organic growth strategies in the home medical devices market. The home medical devices majorly consists of the players such as F. Hoffmann-La Roche Ltd., General Electric Company, Abbott, Koninklijke Philips N.V., B. Braun Melsungen AG, Johnson and Johnson Services, Inc., Medtronic, Medline Industries, Inc., Baxter International Inc., and Invacare Corporation among others. Some of the activities undertaken by the company, which have promoted its growth are, product launch, approvals, partnership and strategy and business planning. Companies such as F. Hoffmann-la Roche ltd., Abbott, Koninklijke Philips N.V., B. Braun Melsungen AG, Medtronic and others have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market.
Below is the list of the growth strategies done by the players operating in the home medical devices market:
|
Year |
News |
|
Mar-2021 |
Roche has acquired GenMark Diagnostics, Inc. at a price of US$ 1.8 billion. Acquisition of GenMark is expected to broaden the diagnostics portfolio of Roche for home medical devices. |
|
Apr-2020 |
B. Braun received US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for use of Infusion Pumps with Nebulizers to treat COVID-19 patients.B. Braun’s Perfusor Space Syringe Infusion Pump, Infusomat Space Volumetric Infusion Pump, and Outlook ES Pump systems for use in the “tracheal delivery of continuous nebulized medications into a nebulizer to treat patients of all ages with or suspected of having the Coronavirus Disease 2019 (COVID-19) and to decrease the exposure of healthcare providers (HCP) to such patients during the COVID-19 pandemic. |
|
Jun-2019 |
Abbott Launches First-Ever Rapid Point-Of-Care Hba1c Test to Aid in The Diagnosis of Diabetes. The Afinion HbA1c Dx assay is the first and only rapid point-of-care test approved by the U.S. Food and Drug Administration (FDA) to aid healthcare provider in the diagnosis of diabetes and the assessment of patients’ risk of developing the condition. |
|
Jan-2018 |
GE Healthcare and Roche Ltd. entered into partnership to develop diagnostic platform to improve critical care treatment. This partnership will apply advanced analytics to in-vivo data from GE’s medical imaging and monitoring equipment with in-vitro data from Roche’s biomarkers, sequencing portfolio, and tissue pathology. |
